Acute coronary syndrome (ACS) is a costly condition for health service provision yet variation in the delivery of care between hospitals persists. A composite measure of adherence with evidence-based clinical-process indicators (CPIs) could better inform hospital performance reporting and clinical outcomes in the management of ACS.
Introduction
Acute coronary syndrome (ACS) accounts for more than half of healthcare expenditure for cardiovascular disease, 1 yet despite this, the quality of the care delivered within and between hospitals varies widely. 2 Moreover, the efficacy of standard clinical guidelines on adherence is unknown due to the lack of reporting metrics.
Results from previous local and international studies demonstrate a correlation between variable adherence with evidence-based care and adverse clinical events. 3, 4 These studies also suggest that variation in patient characteristics, hospital clinical services and systems of care may be contributing factors. In Australia, health departments and national bodies such as the National Health Performance Authority (NHPA) and the Australian Commission on Safety and Quality in Health Care (ACSQHC) have identified in-hospital management of ACS as a priority for health service provision evaluation. However, while evidence-based minimum clinical standards have been defined to guide medical care, 5 there is limited capacity to report on adherence with guideline recommended treatment as a measure of hospital performance in the management of ACS. In Australia, the traditional method of assessing quality of care for ACS has been in-hospital mortality associated with acute myocardial infarction (AMI), yet relatively few patients die in-hospital as a result of an ACS. 6 Measuring adherence to several evidence-based clinical process measures with patient reported outcomes enables overall appraisal of quality of care and is an alternative option to reporting a single outcome measure such as mortality. Reporting multiple patient level process measures also takes into account the complexity of the care provided and differentiates those care practices that lead to the highest (and lowest) quality of care, to produce important insights into how care is delivered. 7 A composite measure of adherence with multiple evidence-based clinical process indicators (CPIs) together with patient-reported outcomes would support hospital performance reporting and guide the direction of quality improvement initiatives, to reduce variation in clinical care between hospitals. 1, 8, 9 Using CPIs in this way provides clinicians and health administrators with measures that are easy to interpret and facilitate comparisons between hospitals with defined evidence-based performance targets, to support performance improvement. 10, 11 Despite evidence that composite scores discriminate performance more readily than a single performance measure, 11, 12 a composite quality score in the management of ACS has yet to be developed in the Australian context. The aim of this study is to demonstrate the importance of adherence to evidence-based indicators by quantifying relationships between a hospital level composite quality adherence score and multiple patient level risk-adjusted outcomes. The objective is to use the quality composite score to (i) measure variation in adherence to evidence-based CPIs between hospitals and (ii) determine if high levels of adherence (as measured by the quality composite score) are associated with lower observed and risk-adjusted in-hospital clinical events, in-hospital death and readmission to hospital for ACS and death at 6 months.
Methods

Study population
We used patient and hospital level data from the Cooperative National Registry of Acute Coronary Care Guideline Adherence and Clinical Events (CONCORDANCE). CONCORDANCE is a prospective, observational clinical quality registry designed within a comparative effectiveness research (CER) framework that captures and describes overall adherence with evidence-based care on the in-hospital management of ACS. 13 CONCORDANCE initially reported outcomes on the management of ACS from 10 Australian hospitals in 2009. The number of participating hospitals expanded to 19 in 2011, and additional hospitals joined the registry over time so that in 2015, 41 hospitals are contributing data. The first 10 consecutively admitted ACS patients per month are enrolled into the registry, and patient-reported outcomes are collected at 6 months, systematically using a standard data collection form by trained research coordinators located at the site where the patient was enrolled. The CONCORDANCE registry uses standardized definitions, and clinical data are abstracted by trained hospital staff and audited to ensure accuracy and consistency with the registry protocol. Participating hospitals are predominantly principal referral hospitals, that is, 'located in major cities with more than 20 000, and regional hospitals with more than 16 000 acute (case mix-adjusted) separations per year'. There is a broad geographical distribution of hospitals in this cohort, and the availability of hospitals are considered to be moderately accessible, accessible or highly accessible by the Accessibility and Remoteness Index of Australia (ARIA).
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Inclusion and exclusion criteria
The patient population included in this analysis are those patients eligible for registry inclusion based on symptoms of an ACS and one or more of either ST segment electrocardiographic (ECG) changes of .0.5 mm, and/or elevation of cardiac biomarkers, new or previous documentation of heart disease or symptoms of an ACS and/or two high-risk features of ACS including haemodynamic compromise (BP , 90 and HR . 100), left ventricular systolic dysfunction (LVEF , 40%), presence of known diabetes and/or documentation of chronic kidney disease (estimated GFR , 60 mLs/min). Patients admitted to hospital with a co-existent condition such as trauma or bleeding or those patients hospitalized for ,24 h are excluded, with the exception of those patients who died within 24 h of admission and death was attributed to an ACS. Additionally, patients with a non-ACS diagnosis and hospitals with fewer than 10 patients' data were excluded from these analyses.
Clinical process indicators measured
Using the collected data, CONCORDANCE reports on 14 CPIs that reflect adherence to Class I, Class Ia, Class II and Class IIa guideline recommended care, with levels of evidence A, B, and C. 1, 2 CPIs included in this analysis, and routinely reported by the registry provide robust measures of systems of care and are associated with improved clinical outcomes. Adherence with CPIs was determined using the All or None Approach 15 -17 and aggregated to provide a composite measure of adherence with evidence-based CPIs. The All or None Approach counts the number of eligible patients receiving each required care process (numerator) against the total number of patients eligible for this process (denominator). For example, only ST elevation MI (STEMI) patients were included in adherence measures for primary percutaneous intervention (PPCI) and/or thrombolysis and only patients who survived beyond 12 h were included in the CPIs for acute treatment. Those patients surviving to hospital discharge were included in measures for access to discharge therapies and referral to secondary prevention.
Hospital composite adherence score
Patients were grouped by presenting hospital, and the proportion of patients receiving each care process at each site was determined. The next step was to calculate the mean of the proportion adherence values within each hospital to determine the composite measure of hospital adherence with all CPIs. The higher adherence value represented greater B. Aliprandi-Costa et al.
compliance with clinical processes. The mean for each hospital was then ordered from highest to lowest, and hospital adherence tertiles were determined 18 ( Table 1) .
Hospital clinical services
The characteristics of hospitals captured by the registry and reported here to describe clinical services include the location of the hospital and details of pre-hospital care. For example, the care provided in coordination with the ambulance service and the hospital local area health district for the direct transport of acute ACS patients to a PCI-capable hospital and ambulance 12-lead ECG recording capability. In-hospital clinical services included the presence of a cardiac catheter lab, a percutaneous coronary intervention (PCI) service, cardiac surgery and echocardiography. In-hospital care processes were also captured, including ACS risk stratification on admission to hospital, a clinical pathway for the transfer of STEMI patients from the Emergency Department (ED) to a PCI-capable hospital; single call activation of the cardiac catheter lab for STEMI; a pathway to guide the prescription of evidence-based medical therapy, the presence of in-hospital secondary prevention services and processes for the referral of ACS patients to outpatient secondary prevention and heart failure services.
Outcome measures
The outcome measures of interest were aggregated in-hospital major adverse events (defined as episodes of heart failure, cardiogenic shock, recurrent ischaemia, in-hospital MI or re-MI, cardiac arrest, stroke and acute renal failure), in-hospital mortality and mortality and readmission for ACS at 6 months following hospital discharge.
Analysis
Statistical analyses were conducted using SAS version 9.4 SAS Institute Inc. Categorical variables are presented as proportions, and continuous variables are presented as means with standard deviation (SD). Chi-squared analysis determined the probability for a difference (a ¼ 0.05) between hospital adherence tertiles 1 and 3 for patient baseline characteristics, and differences in observed rates of in-hospital clinical events, in-hospital mortality and re-admission to hospital and death. As this is an exploratory analysis, no adjustment to alpha was made to account for multiple testing. Odds ratios for an association between hospital adherence tertiles 1 and 3 for in-hospital events, survival at hospital discharge, survival at 6 months and readmission to hospital for ACS at 6 months were determined using the generalized estimating equation (GEE) to model tertile and their interaction with clustering on hospital; and the GRACE risk score 19 to adjust for a difference in presenting patient risk. Hospital data were complete for 75% of the cohort and 66.7% of patients had complete follow-up data at 6 months.
Results
This analysis comprised CONCORDANCE registry data on 7444 patients with a definite ACS diagnosis of STEMI (n ¼ 2306) and NSTEACS (5138) Variation in the hospital-specific composite quality score
The mean of CPI adherence per hospital as the quality composite score is presented in Figure 1 . The composite of clinical process indicators as a measure of hospital performance composite of CPIs was 79% among tertile 1 hospitals; 69.8% among tertile 2 hospitals and 56% among hospitals in tertile 3 (P , 0.0001).
In aggregate, the mean hospital composite adherence with CPIs in this cohort was 68.3% (SD 21.7) with 10 of the 14 hospitals within tertile 1 achieving greater than 75% adherence with the composite of evidence-based CPIs ( Figure 1 ).
Patient baseline characteristics and hospital clinical services by CPI adherence tertile
Patient admission characteristics Patient admission characteristics by hospital adherence tertile are presented in Table 2 . Compared with patients treated in hospitals in tertile 3, patients treated in tertile 1 hospitals were more likely to be younger (P , 0.0001) males (P , 0.0001) with ST elevation (P , 0.0001) or other ischaemic abnormalities on their admission electrocardiograph (ECG) (P , 0.0001). Patients treated in tertile 3 hospitals were therefore older and were more likely to be female with a prior history of heart disease including prior acute myocardial infarction (AMI) (P , 0.0001) and/or prior congestive heart failure (CHF) (P , 0.0001) and were more likely to have undergone previous revascularization including PCI (P , 0.0050) and/or coronary artery bypass grafts (CABG) (P , 0.0001). Patients in tertile 3 hospitals were also more likely to be frail (P , 0.0001) with a greater burden of risk factors for heart disease including hypertension (P , 0.0018), dyslipidaemia (P , 0.0010), diabetes (P , 0.0001), and renal impairment (P , 0.0001) and had a higher admission GRACE risk score 19 (P , 0.0200).
Hospital clinical services
Characteristics of the hospital clinical services captured by the registry are shown in Figure 2 . All hospitals in tertile 1 had a cardiac catheter lab with a primary PCI (PPCI) services (P , 0.0012). Most of these hospitals had systems of care such as single call activation of the cardiac catheter lab, cardiac catheter lab activation enroute to hospital by ambulance and the expedient arrival of the cardiac catheter lab team to hospital within 30 min of notification. Only one-third of tertile 3 hospitals were able to provide these clinical services, and only 50% of hospitals in adherence tertile 3 had a process for the rapid transfer of STEMI patients from the emergency department to a PCI-capable hospital for PPCI or rescue PCI. Importantly, the majority of hospitals in either hospital adherence tertile 1 or tertile 3 had an arrangement with the ambulance service to divert STEMI patients directly to a PCI-capable hospital within their area health service or local health district. Except for the presence of coronary angiography services and consequently PCI, access to specialist cardiology services was equitable in both hospital adherence tertiles 1 and 3 and there was no significant difference in the availability of exercise stress test, echocardiography and stress-echocardiography. Similarly, there was no difference in access to in-hospital secondary prevention; objective risk assessment; outpatient exercise programmes, outpatient heart failure programmes or the presence of a full-time or part-time secondary prevention coordinator. Nonetheless, hospitals in adherence tertile 1 were significantly more likely to refer patients to secondary prevention programmes (P , 0.0001).
Adherence with evidence-based CPIs by hospital adherence tertile
The evidence-based CPIs are presented in Table 3 . Comparisons between hospital adherence tertiles 1 and 3 revealed significant variation in adherence with all CPIs (P , 0.0001) except risk stratification of NSTEACS on hospital admission which occurred ,15% of the time overall. Hospitals in tertile 1 were found to provide greater access to reperfusion for STEMI (P , 0.0001), and more frequently provided access to coronary angiography within 48 h (P , 0.0001) and coronary angiography at any time during hospital admission (P , 0.0001). Tertile 1 hospitals also provided left ventricular assessment more frequently (P , 0.0001) and were significantly more likely to prescribe evidence-based medical therapies including clopidogrel, prasugrel or ticagrelor in-hospital (P , 0.0001) and at hospital discharge (P , 0.0001), together with beta-blockers (P , 0.0001); statins (P , 0.0001) and ACE-inhibitor or angiotensin receptor blockers (ARB) or both at discharge (P , 0.0001). Overall, there was a 15.9% difference between tertiles 1 and 3 hospitals for the prescription of four or more recommended therapies (including of aspirin, clopidogrel, prasugrel or ticagrelor; statin; beta-blocker and either ACE or ARB or both) (P , 0.0001).
Observed (unadjusted) outcomes
Observed outcomes reveal more than 92.2% of patients admitted to hospital with an ACS survive to hospital discharge. There were fewer in-hospital deaths due to an ACS recorded in tertile 1 hospitals; 2.5% (3141/3222) compared with 7.8% (2074/2250) in tertile 3 hospitals (P , 0.0001). Overall, patients admitted to tertile 1 hospitals were less likely to experience an adverse event in-hospital; 18.9% (608/3222) compared with 32.6% (734/2250) in tertile 3 hospitals (P , 0.0001). Of those patients surviving to hospital discharge, 97% (1792/1843) of patients admitted to tertile 1 hospitals were alive at 6 months following their index admission compared with 92% (1270/1375) of patients in tertile 3 hospitals (P , 0.0001). Likewise, fewer patients treated in tertile 1 hospitals required readmission to hospital for an ACS within 6 months, 17.6% (323/1835) compared with 21% (290/1374) of patients treated in tertile 3 hospitals (P , 0.0125). (Figure 3) . Patients with a contraindication to the treatment are excluded.
The composite of clinical process indicators as a measure of hospital performance
Discussion
In this Australian ACS cohort, the composite quality score reveals variation in hospital adherence with evidence-based care. With risk adjustment, there was an association between greater adherence with the composite of CPIs, reduced in-hospital adverse events and improved survival at hospital discharge. Proportionally, more clinical services specific to the treatment of an acute ACS event such as STEMI were located in tertile 1 hospitals. There were fewer cardiac catheter labs in tertile 3 hospitals and consequently less angiography. Overall, tertile 1 hospitals were more likely than tertile 3 hospitals to complete coronary angiography within 48 h of patient presentation, provide left ventricular assessment, prescribe evidence-based therapies inhospital and at discharge and refer patients to secondary prevention services.
Despite echocardiography being available across all hospitals, patients attending hospitals in tertile 3 were less likely to receive left ventricular assessment that suggests perhaps either a system failure or insufficient resources to facilitate routine echocardiography. System failure may also be the likely factor impacting the coordination of care by tertile 3 hospitals to facilitate access to acute services including angiography within 48 h and possibly the prescription of evidence-based medical therapy and patient referral to secondary prevention. This is important as a high proportion of patients attending tertile 3 hospitals had elevated biomarkers and/ or an abnormal ECG on admission to hospital.
The generation a composite score using this methodology 17 demonstrates the utility of the all-or-none approach in the calculation of a composite quality score which is feasible for use by clinicians and hospital administrators to measure and benchmark their performance. The CPIs included in this composite score are derived from guideline recommendations, which, in some instances, are reflective of expert consensus views, and a perception that adherence to these measures is likely to improve outcomes. 21, 22 Indeed, our data would support this. Previously, it has been shown that modelling for coronary artery catheterization did not change the association between an opportunity-based composite score (OBCS) and clinical outcomes, 12 consequently we did not adjust for the relative benefits of individual therapies or interventions in the calculation of this composite score. Similarly, the rationale for counting each of the medical therapies individually, and the relative value of including the group of four or more is that we provide a more accurate picture of the impact of prescription of all evidence-based therapies on being discharged alive and survival at 6 months. Reporting both the prescription of individual therapies and four or more medical therapies provided another opportunity for the hospital to perform. In this observational registry cohort, data were normally distributed across each tertile. There were a large number of mandatory variables built into the database. In addition, where data were incomplete, efforts were made to contact sites and the data acquired. Data elements that remained unavailable after this process was left as missing, as is usually applied in the analysis of observational cohorts. 18 The nature of clinician-driven quality improvement is clearly dynamic. In this analysis, there is a likely cumulative influence of the presence of acute care services and strategies such as the rapid identification of STEMI on adherence with other clinical processes, for instance the prescription of evidence-based therapies. While we recognize that reasons for non-adherence with evidencebased care are difficult to capture in a clinical registry, this composite quality score has the potential to provide guidance on which failures of care can be detected and acted upon quickly by clinicians and health service providers to improve the quality of hospitalbased care for ACS. Figure 3 Risk-adjusted in-hospital outcomes and outcomes at 6 months.
Our findings suggest that expanding the performance framework to include a composite measure of adherence with evidence-based clinical processes is a valuable quality instrument that can be applied periodically in addition to reporting health outcomes alone. Furthermore, the provision of a continuous and comprehensive cycle of data collection is feasible outside health service research, using health technologies such as the electronic medical record as the vehicle for capturing and reporting patient level clinical processes and patient outcomes. This is particularly salient as there are few datasets available by which to report performance as a continuous cycle of data collection and audit or to provide feedback to hospitals benchmarked with peer comparisons as an ongoing resource for quality improvement purposes. Reporting quality measures to health service providers is problematic when there is limited capacity to report more broadly on adherence with evidence-based care, dissimilar hospital infrastructure for data collection and variable access to health information technology between hospitals. 23 In the current Australian environment of activity-based funding (ABF) to determine how and where clinical services are provided, there is potential to expand the performance framework to include process measures of effective healthcare delivery into routine health service performance reporting. 24 Additionally, the method for calculating the quality composite score could be generated at the local hospital level by clinicians, health administrators and by health administrative data collection agencies to inform hospital performance reporting. The calculation of a composite quality score to measure hospital performance relies only on high-quality data capture and provides a tool that is interpretable by all stakeholders of ACS care to identify areas of health service provision for system improvement. Reporting quality measures of hospital performance has the potential to engage clinicians in self-assessment and professional bodies in ongoing education to co-operatively monitor patient outcomes and health service delivery and inform health policy development.
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Limitations
These data, although collected systematically, are observational and other factors not investigated here may also impact hospital performance. Mortality rates reported by the registry were small overall, and several hospitals contributed comparatively fewer patients, impacting our ability to determine a stronger association between hospital adherence tertiles and mortality at 6 months. The broader influences of patient risk and clinical services have previously been evaluated, 26 and it is clear from this analysis that patient characteristics and clinical services including greater availability of coronary angiography differ between hospitals. These issues and others such as changes in medical/nursing workforce and the impact of clinical leadership on clinician-driven implementation of evidencebased care are beyond the scope of this study.
Conclusion
In this Australian ACS cohort, the composite measure of adherence to evidence-based CPIs reveals variation between hospitals in the quality of care for ACS. Risk-adjusted analyses confirmed an association between higher hospital adherence with evidence-based CPIs and lower in-hospital clinical events, demonstrating the utility of a composite quality score to measure and report hospital performance in the management of ACS. A hospital performance framework that includes patient level evidence-based process measures would better inform the quality improvement process and provide greater scope for engaging clinicians and hospital administrators in evidence-based quality improvement initiatives. 8, 25 
